The DOI matches its Crossref record; 139 of the 139 references it cites were found in a registry or an index.
The Bare Lymphocyte Syndrome and the Regulation of MHC Expression
Open accessAbstract
The bare lymphocyte syndrome (BLS) is a hereditary immunodeficiency resulting from the absence of major istocompatibility complex class II (MHCII) expression. Considering the central role of MHCII molecules in the development and activation of CD4+T cells, it is not surprising that the immune system of the patients is severely impaired. BLS is the prototype of a “disease of gene regulation.” The affected genes encode RFXANK, RFX5, RFXAP, and CIITA, four regulatory factors that are highly specific and essential for MHCII genes. The first three are subunits of RFX, a trimeric complex that binds to all MHCII promoters. CIITA is a non-DNA-binding coactivator that functions as the master control factor for MHCII expression. The study of RFX and CIITA has made major contributions to our comprehension of the molecular mechanisms controlling MHCII genes and has made this system into a textbook model for the regulation of gene expression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Szer, J. (1999) · Medical Journal of Australia · doi:10.5694/j.1326-5377.1999.tb127745.x · Cited by 3,353
Amino Acid Sequences Common to Rapidly Degraded Proteins: The PEST Hypothesis
Rogers, S., Wells, R., & Rechsteiner, M. (1986) · Science · doi:10.1126/science.2876518 · Cited by 2,537
JAKS AND STATS: Biological Implications
Leonard, W. J., & O'Shea, J. J. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.293 · Cited by 1,804
Regulation of MHC Class II Expression by Interferon-γ Mediated by the Transactivator Gene CIITA
Steimle, V., Siegrist, C.-A., Mottet, A., Lisowska-Grospierre, B., & Mach, B. (1994) · Science · doi:10.1126/science.8016643 · Cited by 898
Steimle, V (1993) · Cell · doi:10.1016/0092-8674(93)90685-j · Cited by 864
The molecular biology of the CCAAT-binding factor NF-Y
Mantovani, R. (1999) · Gene · doi:10.1016/s0378-1119(99)00368-6 · Cited by 861
Assembly, Transport, and Function of MHC Class II Molecules
Cresswell, P. (1994) · Annual Review of Immunology · doi:10.1146/annurev.immunol.12.1.259 · Cited by 807
Nod1, an Apaf-1-like Activator of Caspase-9 and Nuclear Factor-κB
Inohara, N., Koseki, T., del Peso, L., Hu, Y., Yee, C., Chen, S., Carrio, R., Merino, J., Liu, D., Ni, J., et al. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.21.14560 · Cited by 742
Signaling and Transcription in T Helper Development
Murphy, K. M., Ouyang, W., Farrar, J. D., Yang, J., Ranganath, S., Asnagli, H., Afkarian, M., & Murphy, T. L. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.451 · Cited by 633
Imada, K., & Leonard, W. J. (2000) · Molecular Immunology · doi:10.1016/s0161-5890(00)00018-3 · Cited by 610
Sequences And Factors: A Guide To Mhc Class-Ii Transcription
Glimcher, L. (1992) · Annual Review of Immunology · doi:10.1146/annurev.immunol.10.1.13 · Cited by 534
Huang, M., Zhou, Z., & Elledge, S. J. (1998) · Cell · doi:10.1016/s0092-8674(00)81601-3 · Cited by 507
Muhlethaler-Mottet, A. (1997) · The EMBO Journal · doi:10.1093/emboj/16.10.2851 · Cited by 507
REGULATION OF MHC CLASS II GENES: Lessons from a Disease
Mach, B., Steimle, V., Martinez-Soria, E., & Reith, W. (1996) · Annual Review of Immunology · doi:10.1146/annurev.immunol.14.1.301 · Cited by 486
Self-citationBenoist, C., & Mathis, D. (1990) · Annual Review of Immunology · doi:10.1146/annurev.iy.08.040190.003341 · Cited by 457
CD1-restricted CD4+ T cells in major histocompatibility complex class II-deficient mice.
Cardell, S., Tangri, S., Chan, S., Kronenberg, M., Benoist, C., & Mathis, D. (1995) · The Journal of experimental medicine · doi:10.1084/jem.182.4.993 · Cited by 384
Invariant Chain Structure and MHC Class II Function
Cresswell, P. (1996) · Cell · doi:10.1016/s0092-8674(00)81025-9 · Cited by 380
Muhlethaler-Mottet, A., Di Berardino, W., Otten, L. A., & Mach, B. (1998) · Immunity · doi:10.1016/s1074-7613(00)80468-9 · Cited by 377
Self-citationMasternak, K., Muhlethaler-Mottet, A., Villard, J., Zufferey, M., Steimle, V., & Reith, W. (2000) · Genes & Development · doi:10.1101/gad.14.9.1156 · Cited by 355
Self-citationChang, C.-H., Guerder, S., Hong, S.-C., van Ewijk, W., & Flavell, R. A. (1996) · Immunity · doi:10.1016/s1074-7613(00)80681-0 · Cited by 350
Steimle, V, Durand, B., Barras, E., Zufferey, M., Hadam, M. R., Mach, B., & Reith, W. (1995) · Genes & Development · doi:10.1101/gad.9.9.1021 · Cited by 338
Self-citationMiller, D. M., Rahill, B. M., Boss, J. M., Lairmore, M. D., Durbin, J. E., Waldman, J. W., & Sedmak, D. D. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.5.675 · Cited by 337
Chang, C. H., Fontes, J. D., Peterlin, M., & Flavell, R. A. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.4.1367 · Cited by 329
Structure of the winged-helix protein hRFX1 reveals a new mode of DNA binding
Gajiwala, K. S., Chen, H., Cornille, F., Roques, B. P., Reith, W., Mach, B., & Burley, S. K. (2000) · Nature · doi:10.1038/35002634 · Cited by 317
Self-citationMasternak, K., Barras, E., Zufferey, M., Conrad, B., Corthals, G., Aebersold, R., Sanchez, J.-C., Hochstrasser, D. F., Mach, B., & Reith, W. (1998) · Nature Genetics · doi:10.1038/3081 · Cited by 276
Self-citationClass II transactivator regulates the expression of multiple genes involved in antigen presentation.
Chang, C. H., & Flavell, R. A. (1995) · The Journal of experimental medicine · doi:10.1084/jem.181.2.765 · Cited by 267
Kanazawa, S., Okamoto, T., & Peterlin, B. M. (2000) · Immunity · doi:10.1016/s1074-7613(00)80159-4 · Cited by 262
Reith, W., Satola, S., Sanchez, C. H., Amaldi, I., Lisowska-Grospierre, B., Griscelli, C., Hadam, M. R., & Mach, B. (1988) · Cell · doi:10.1016/s0092-8674(88)90389-3 · Cited by 255
Self-citationJuxtaposed regions of extensive and minimal linkage disequilibrium in human Xq25 and Xq28
Taillon-Miller, P., Bauer-Sardiña, I., Saccone, N. L., Putzel, J., Laitinen, T., Cao, A., Kere, J., Pilia, G., Rice, J. P., & Kwok, P.-Y. (2000) · Nature Genetics · doi:10.1038/77100 · Cited by 254
RFXAP, a novel subunit of the RFX DNA binding complex is mutated in MHC class II deficiency
Durand, B. (1997) · The EMBO Journal · doi:10.1093/emboj/16.5.1045 · Cited by 227
Regulation of MHC gene expression
Ting, J. P.-Y., & Baldwin, A. S. (1993) · Current Opinion in Immunology · doi:10.1016/0952-7915(93)90074-3 · Cited by 212
Gobin, S. J. P., Peijnenburg, A., Keijsers, V., & van den Elsen, P. J. (1997) · Immunity · doi:10.1016/s1074-7613(00)80348-9 · Cited by 210
Induction of MHC Class I Expression by the MHC Class II Transactivator CIITA
Martin, B. K., Chin, K.-C., Olsen, J. C., Skinner, C. A., Dey, A., Ozato, K., & Ting, J. P.-Y. (1997) · Immunity · doi:10.1016/s1074-7613(00)80347-7 · Cited by 208
Zhu, X.-S., Linhoff, M. W., Li, G., Chin, K.-C., Maity, S. N., & Ting, J. P.-Y. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.16.6051-6061.2000 · Cited by 201
RFX Proteins, a Novel Family of DNA Binding Proteins Conserved in the Eukaryotic Kingdom
Emery, P., Durand, B., Mach, B., & Reith, W. (1996) · Nucleic Acids Research · doi:10.1093/nar/24.5.803 · Cited by 200
Self-citationZhong, G., Fan, T., & Liu, L. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.12.1931 · Cited by 196
Regulation of transcription of MHC class II genes
Boss, J. M. (1997) · Current Opinion in Immunology · doi:10.1016/s0952-7915(97)80166-5 · Cited by 195
Genomic structure and function in the MHC
Trowsdale, J. (1993) · Trends in Genetics · doi:10.1016/0168-9525(93)90205-v · Cited by 188
Piskurich, J. F., Linhoff, M. W., Wang, Y., & Ting, J. P.-Y. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.1.431 · Cited by 187
CREB Regulates MHC Class II Expression in a CIITA-Dependent Manner
Moreno, C. S., Beresford, G. W., Louis-Plence, P., Morris, A. C., & Boss, J. M. (1999) · Immunity · doi:10.1016/s1074-7613(00)80015-1 · Cited by 184
O'Keefe, G. M., Nguyen, V. T., & Benveniste, E. N. (1999) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199904)29:04<1275::aid-immu1275>3.0.co;2-t · Cited by 179
Riley, J. L., Westerheide, S. D., Price, J. A., Brown, J. A., & Boss, J. M. (1995) · Immunity · doi:10.1016/1074-7613(95)90033-0 · Cited by 177
Lee, Y. J., Han, Y., Lu, H. T., Nguyen, V, Qin, H., Howe, P. H., Hocevar, B. A., Boss, J. M., Ransohoff, R. M., & Benveniste, E. N. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.5.2065 · Cited by 177
Reith, W., Siegrist, C. A., Durand, B., Barras, E., & Mach, B. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.2.554 · Cited by 176
Self-citationRejection of mouse sarcoma cells after transfection of MHC class II genes.
Ostrand-Rosenberg, S., Thakur, A., & Clements, V (1990) · The Journal of Immunology · doi:10.4049/jimmunol.144.10.4068 · Cited by 171
Kretsovali, A., Agalioti, T., Spilianakis, C., Tzortzakaki, E., Merika, M., & Papamatheakis, J. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.11.6777 · Cited by 167
In vivo footprinting of MHC class II genes: bare promoters in the bare lymphocyte syndrome
Kara, C., & Glimcher, L. (1991) · Science · doi:10.1126/science.1902592 · Cited by 167
Nagarajan, U. M., Louis-Plence, P., DeSandro, A., Nilsen, R., Bushey, A., & Boss, J. M. (1999) · Immunity · doi:10.1016/s1074-7613(00)80016-3 · Cited by 166
Piskurich, J. F., Wang, Y., Linhoff, M. W., White, L. C., & Ting, J. P. ‐. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.1.233 · Cited by 160
Silacci, P., Mühlethaler‐Mottet, A., Steimle, V., Reith, W., & Mach, B. (1994) · The Journal of Experimental Medicine · doi:10.1084/jem.180.4.1329 · Cited by 158
Self-citationZhou, H., & Glimcher, L. H. (1995) · Immunity · doi:10.1016/1074-7613(95)90034-9 · Cited by 154
Piskurich, J. F., Wang, Y., Linhoff, M. W., White, L. C., & Ting, J. P. ‐. (1998) · PubMed · Cited by 153
Nonclassical MHC Class II Molecules
Alfonso, C., & Karlsson, L. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.113 · Cited by 153
Fontes, J. D., Kanazawa, S., Jean, D., & Peterlin, B. M. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.1.941 · Cited by 144
The role of interferon regulatory factors in the interferon system and cell growth control
Harada, H., Taniguchi, T., & Tanaka, N. (1998) · Biochimie · doi:10.1016/s0300-9084(99)80017-0 · Cited by 144
Wright, K. L., Vilen, B. J., Itoh-Lindstrom, Y., Moore, T. L., Li, G., Criscitiello, M. F., Cogswell, P. C., Clarke, J. B., & Ting, J. P. ‐. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06721.x · Cited by 139
Modulation of Major Histocompatibility Class II Protein Expression by Varicella-Zoster Virus
Abendroth, A., Slobedman, B., Lee, E. Y., Mellins, E., Wallace, M. R., & Arvin, A. M. (2000) · Journal of Virology · doi:10.1128/jvi.74.4.1900-1907.2000 · Cited by 139
Scholl, T., Mahanta, S. K., & Strominger, J. L. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.12.6330 · Cited by 137
The class II trans-activator CIITA interacts with the TBP-associated factor TAFII32
Fontes, J. D., Jiang, B., & Peterlin, B. M. (1997) · Nucleic Acids Research · doi:10.1093/nar/25.12.2522 · Cited by 126
TGF-beta attenuates the class II transactivator and reveals an accessory pathway of IFN-γ action
Nandan, D., & Reiner, N. E. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.3.1095 · Cited by 121
Bénichou, B., & Strominger, J. L. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.10.4285 · Cited by 120
Quantitative control of MHC class II expression by the transactivator CIITA
Otten, L., Steimle, V., Bontron, S., & Mach, B. (1998) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199802)28:02<473::aid-immu473>3.0.co;2-e · Cited by 117
Self-citationGobin, S. J. P., Peijnenburg, A., van Eggermond, M. C. J. A., van Zutphen, M., den Berg, R. V., & van den Elsen, P. J. (1998) · Immunity · doi:10.1016/s1074-7613(00)80636-6 · Cited by 114
Lee, Y. J., & Benveniste, E. N. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.4.1559 · Cited by 113
Mahanta, S. K., Scholl, T., Yang, F.-C., & Strominger, J. L. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.12.6324 · Cited by 111
Wojciechowski, W., Sanctis, J. B. D., Skamene, E., & Radzioch, D. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.5.2688 · Cited by 109
Control of MHC class II gene expression in autoimmune, infectious, and neoplastic diseases.
Guardiola, J., & Maffei, A. (1993) · PubMed · Cited by 109
Hake, S. B., Masternak, K., Kammerbauer, C., Janzen, C. J., Reith, W., & Steimle, V. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.20.7716-7725.2000 · Cited by 108
Self-citationThe two novel MHC class II transactivators RFX5 and CIITA both control expression of HLA-DM genes
Kern, I., Steimle, V., Siegrist, C., & Mach, B. (1995) · International Immunology · doi:10.1093/intimm/7.8.1295 · Cited by 107
Self-citationSisk, T. J., Gourley, T. S., Roys, S., & Chang, C. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.5.2511 · Cited by 106
Lu, H., Riley, J. L., Babcock, G. T., Huston, M. M., Stark, G. R., Boss, J. M., & Ransohoff, R. M. (1995) · The Journal of Experimental Medicine · doi:10.1084/jem.182.5.1517 · Cited by 106
Klein, C., Cavazzana, M., Deist, F. L., Jabado, N., Benkerrou, M., Blanche, S., Lisowska‐Grospierre, B., Griscelli, C., & Fischer, A. (1995) · Blood · doi:10.1182/blood.v85.2.580.580 · Cited by 104
Chin, K.-C., Li, G. G.-X., & Ting, J. P. ‐. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.6.2501 · Cited by 101
Shared regulatory elements in the promoters of MHC class I and class II genes
van den Elsen, P. J., Peijnenburg, A., van Eggermond, M. C. J. A., & Gobin, S. J. P. (1998) · Immunology Today · doi:10.1016/s0167-5699(98)01287-0 · Cited by 101
GTP Binding by Class II Transactivator: Role in Nuclear Import
Harton, J. A., Cressman, D. E., Chin, K.-C., Der, C. J., & Ting, J. P. ‐. (1999) · Science · doi:10.1126/science.285.5432.1402 · Cited by 99
Villard, J., Peretti, M., Masternak, K., Barras, E., Caretti, G., Mantovani, R., & Reith, W. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.10.3364-3376.2000 · Cited by 96
Self-citationMethylation of Class II trans-Activator Promoter IV: A Novel Mechanism of MHC Class II Gene Control
Morris, A. C., Spangler, W. E., & Boss, J. M. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.8.4143 · Cited by 95
Cooperative binding between factors RFX and X2bp to the X and X2 boxes of MHC class II promoters.
Reith, W., Kobr, M., Emery, P., Durand, B., Siegrist, C., & Mach, B. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)32121-x · Cited by 94
Self-citationAssociations and Interactions between Bare Lymphocyte Syndrome Factors
DeSandro, A. M., Nagarajan, U. M., & Boss, J. M. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.17.6587-6599.2000 · Cited by 94
IFN-gamma regulation of the type IV class II transactivator promoter in astrocytes.
Dong, Y., Rohn, W. M., & Benveniste, E. N. (1999) · PubMed · Cited by 89
Mice lacking the transcription factor CIITA--a second look.
Williams, G. S., Malin, M., Vremec, D., Chang, C., Boyd, R. L., Benoist, C. O., & Mathis, D. J. (1998) · International Immunology · doi:10.1093/intimm/10.12.1957 · Cited by 89
Developing and shedding inhibitions: how MHC class II molecules reach maturity
Busch, R., & Mellins, E. (1996) · Current Opinion in Immunology · doi:10.1016/s0952-7915(96)80105-1 · Cited by 88
A Defect in the Nuclear Translocation of CIITA Causes a Form of Type II Bare Lymphocyte Syndrome
Cressman, D. E., Chin, K.-C., Taxman, D. J., & Ting, J. P.-Y. (1999) · Immunity · doi:10.1016/s1074-7613(00)80017-5 · Cited by 87
DeSandro, A., Nagarajan, U., & Boss, J. (1999) · American Journal of Human Genetics · doi:10.1086/302519 · Cited by 87
Roy, E. L., Mühlethaler‐Mottet, A., Davrinche, C., Mach, B., & Davignon, J. (1999) · Journal of Virology · doi:10.1128/jvi.73.8.6582-6589.1999 · Cited by 82
Self-citationIsolation of a B-cell-specific promoter for the human class II transactivator
Lennon, A., Ottone, C., Rigaud, G., Deaven, L. L., Longmire, J., Fellous, M., Bono, R., & Alcaïde‐Loridan, C. (1997) · Immunogenetics · doi:10.1007/s002510050202 · Cited by 81
Gourley, T. S., Roys, S., Lukacs, N. W., Kunkel, S. L., Flavell, R. A., & Chang, C. (1999) · Immunity · doi:10.1016/s1074-7613(00)80037-0 · Cited by 79
Louis‐Plence, P., Moreno, C. S., & Boss, J. M. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.159.8.3899 · Cited by 79
IFN-γ Regulation of the Type IV Class II Transactivator Promoter in Astrocytes
Dong, Y., Rohn, W. M., & Benveniste, E. N. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.8.4731 · Cited by 75
CIITA activates the expression of MHC class II genes in mouse T cells
Chang, C., Hong, S., Hughes, C. C. W., Janeway, C. A., & Flavell, R. A. (1995) · International Immunology · doi:10.1093/intimm/7.9.1515 · Cited by 74
A Consensus Motif in the RFX DNA Binding Domain and Binding Domain Mutants with Altered Specificity
Emery, P., Strubin, M., Hofmann, K., Bücher, P., Mach, B., & Reith, W. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.8.4486 · Cited by 72
Self-citationClausen, B. E., Waldburger, J., Schwenk, F., Barras, E., Mach, B., Rajewsky, K., Förster, I., & Reith, W. (1998) · Immunity · doi:10.1016/s1074-7613(00)80467-7 · Cited by 72
Self-citationBaskar, S., Clements, V. K., Glimcher, L. H., Nabavi, N., & Ostrand‐Rosenberg, S. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.156.10.3821 · Cited by 69
Bontron, S., Ucla, C., Mach, B., & Steimle, V. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.8.4249 · Cited by 69
Self-citationWright, K. L., Chin, K.-C., Linhoff, M. W., Skinner, C., Brown, J. A., Boss, J. M., Stark, G. R., & Ting, J. P. ‐. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6267 · Cited by 68
Mutation of RFXAP, a Regulator of MHC Class II Genes, in Primary MHC Class II Deficiency
Villard, J., Lisowska‐Grospierre, B., van den Elsen, P. J., Fischer, A., Reith, W., & Mach, B. (1997) · New England Journal of Medicine · doi:10.1056/nejm199709113371104 · Cited by 68
Self-citationItoh-Lindstrom, Y., Piskurich, J. F., Felix, N. J., Wang, Y., Brickey, W. J., Platt, J. L., Koller, B. H., & Ting, J. P. ‐. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.5.2425 · Cited by 67
Itoh-Lindstrom, Y., Piskurich, J. F., Felix, N. J., Wang, Y., Brickey, W. J., Platt, J. L., Koller, B. H., & Ting, J. P. ‐. (1999) · PubMed · Cited by 66
Two complementation groups account for most cases of inherited MHC class II deficiency
Lisowska‐Grospierre, B., Fondanèche, M., Rols, M., Griscelli, C., & Fischer, A. (1994) · Human Molecular Genetics · doi:10.1093/hmg/3.6.953 · Cited by 57
Sartoris, S., Valle, M. T., Barbaro, A. D. L., Tosi, G., Cestari, T., D’Agostino, A., Megiovanni, A. M., Manca, F., & Accolla, R. S. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.2.814 · Cited by 54
Nikcevich, K. M., Piskurich, J. F., Hellendall, R. P., Wang, Y., & Ting, J. P. ‐. (1999) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(99)00117-4 · Cited by 54
Ghosh, N., Piskurich, J. F., Wright, G. M., Hassani, K., Ting, J. P. ‐., & Wright, K. L. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.45.32342 · Cited by 54
MHC Class II Gene Silencing in Trophoblast Cells Is Caused by Inhibition of CIITA Expression
Morris, A. C., Riley, J. L., Fleming, W., & Boss, J. M. (1998) · American Journal of Reproductive Immunology · doi:10.1111/j.1600-0897.1998.tb00423.x · Cited by 52
Bontron, S., Steimle, V., Ucla, C., Eibl, M. M., & Mach, B. (1997) · Human Genetics · doi:10.1007/s004390050403 · Cited by 52
Self-citationTaxman, D. J., Cressman, D. E., & Ting, J. P. ‐. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.3.1410 · Cited by 50
Riegert, P., Andersen, R. B., Bumstead, N., Döhring, C., Dominguez-Steglich, M. A., Engberg, J., Salomonsen, J., Schmid, M., Schwager, J., Skjødt, K., et al. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.3.1243 · Cited by 50
Hauber, I., Gulle, H., Wolf, H. M., Maris, M., Eggenbauer, H., & Eibl, M. M. (1995) · The Journal of Experimental Medicine · doi:10.1084/jem.181.4.1411 · Cited by 48
Schmitt, E. K., & Kück, U. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.13.9348 · Cited by 47
Brown, J. A. (1998) · Nucleic Acids Research · doi:10.1093/nar/26.18.4128 · Cited by 44
Rohn, W. M., Tang, L. P., Dong, Y., & Benveniste, E. N. (1999) · PubMed · Cited by 43
Gönczy, P., Reith, W., Barras, E., Lisowska‐Grospierre, B., Griscelli, C., Hadam, M. R., & Mach, B. (1989) · Molecular and Cellular Biology · doi:10.1128/mcb.9.1.296 · Cited by 41
Self-citationBrown, A., Wright, K. L., & Ting, J. P. ‐. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)74318-x · Cited by 40
Martin, B. K., Frelinger, J. G., & Ting, J. P. ‐. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.11.6663 · Cited by 39
Dissection of functional NF-Y-RFX cooperative interactions on the MHC class II Ea promoter
Caretti, G., Cocchiarella, F., Sidoli, C., Villard, J., Peretti, M., Reith, W., & Mantovani, R. (2000) · Journal of Molecular Biology · doi:10.1006/jmbi.2000.4028 · Cited by 39
Self-citationRohn, W. M., Tang, L. P., Dong, Y., & Benveniste, E. N. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.2.886 · Cited by 39
Quan, V. A., Towey, M., Sacks, S. H., & Kelly, A. P. (1999) · Immunogenetics · doi:10.1007/s002510050579 · Cited by 37
Douhan, J., Lieberson, R., Knoll, J. H. M., Zhou, H., & Glimcher, L. H. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.11.1885 · Cited by 34
Sartoris, S., Tosi, G., Barbaro, A. D. L., Cestari, T., & Accolla, R. S. (1996) · European Journal of Immunology · doi:10.1002/eji.1830261028 · Cited by 30
Characterization of the expressed CIITA allele in the class II MHC transcriptional mutant RJ2.2.5
Brown, J., He, X., Westerheide, S. D., & Boss, J. M. (1995) · Immunogenetics · doi:10.1007/bf00186611 · Cited by 29
Westerheide, S. D. (1999) · Nucleic Acids Research · doi:10.1093/nar/27.7.1635 · Cited by 29
Synergistic induction of HLA class I expression by RelA and CIITA
Girdlestone, J. (2000) · Blood · doi:10.1182/blood.v95.12.3804 · Cited by 29
Han, Y., Zhou, Z.-H. L., & Ransohoff, R. M. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.3.1435 · Cited by 28
Yun, S., Gustafsson, K. T., & Fabre, J. W. (1998) · Transplantation · doi:10.1097/00007890-199807150-00016 · Cited by 26
Genetic and molecular definition of complementation group D in MHC class II deficiency
Fondanèche, M. (1998) · Human Molecular Genetics · doi:10.1093/hmg/7.5.879 · Cited by 25
Han, Y., Zhou, Z.-H. L., & Ransohoff, R. M. (1999) · PubMed · Cited by 25
Peijnenburg, A., den Berg, R. V., van Eggermond, M. C. J. A., Sanal, Ö., Vossen, J. M. J. J., Lennon, A. M., Alcaïde‐Loridan, C., & van den Elsen, P. J. (2000) · Immunogenetics · doi:10.1007/s002510050007 · Cited by 23
Molecular analysis of an MHC class II deficiency patient reveals a novel mutation in the RFX5 gene
Peijnenburg, A., van Eggermond, M. C. J. A., den Berg, R. V., Sanal, X. D., Vossen, J. M. J. J., & van den Elsen, P. J. (1999) · Immunogenetics · doi:10.1007/s002510050501 · Cited by 23
Lefebvre, S., Moreau, P., Dausset, J. B., Carosella, E. D., & Paul, P. (1999) · Placenta · doi:10.1053/plac.1998.0380 · Cited by 23
Peijnenburg, A., van Eggermond, M. C. J. A., Gobin, S. J. P., et al. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.2.794 · Cited by 22
Villard, J., Mühlethaler‐Mottet, A., Bontron, S., Mach, B., & Reith, W. (1999) · International Immunology · doi:10.1093/intimm/11.3.461 · Cited by 22
Self-citationT cell development in a major histocompatibility complex class II‐deficient patient
van Eggermond, M. C. J. A., Rijkers, G. T., Kuis, W., et al. (1993) · European Journal of Immunology · doi:10.1002/eji.1830231031 · Cited by 20
Kielar, M. L., Sicher, S. C., Penfield, J. G., Jeyarajah, D. R., & Lu, C. Y. (2000) · Inflammation · doi:10.1023/a:1007012128392 · Cited by 19
Katan‐Khaykovich, Y., Spiegel, I., & Shaul, Y. (1999) · Journal of Molecular Biology · doi:10.1006/jmbi.1999.3245 · Cited by 17
Tai, A., Zhou, G., Chau, K., & Ono, S. J. (1999) · Molecular Immunology · doi:10.1016/s0161-5890(99)00061-9 · Cited by 17
Steimle, V., & Mach, B. (1995) · Current Opinion in Genetics & Development · doi:10.1016/0959-437x(95)80034-4 · Cited by 16
Self-citationHenwood, J., van Eggermond, M. C., van Boxel-Dezaire, A. H. H., et al. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.156.3.895 · Cited by 14
Bono, M. R., Alcaïde‐Loridan, C., Couillin, P., Letouzé, B., Grisard, M., Jouin, H., & Fellous, M. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.14.6077 · Cited by 12
HLA class II expression in human tumor lines
Blanck, G. (1999) · Microbes and Infection · doi:10.1016/s1286-4579(99)00226-9 · Cited by 11
Bischof, A. (2000) · doi:10.1002/1521-4141(200003)30:3
Cited by
The Inflammasomes: Guardians of the Body
Martinon, F., Mayor, A., & Tschopp, J. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132715 · Cited by 2,436
NODs: intracellular proteins involved in inflammation and apoptosis
Inohara, N., & Nuñez, G. (2003) · Nature Reviews Immunology · doi:10.1038/nri1086 · Cited by 1,064
NOD-LRR PROTEINS: Role in Host-Microbial Interactions and Inflammatory Disease
Inohara, N., Chamaillard, M., McDonald, C., & Nuñez, G. (2005) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.74.082803.133347 · Cited by 991
The NLR Gene Family: A Standard Nomenclature
Ting, J. P.-Y., Lovering, R. C., Alnemri, E. S., Bertin, J., Boss, J. M., Davis, B. K., Flavell, R. A., Girardin, S. E., Godzik, A., Harton, J. A., et al. (2008) · Immunity · doi:10.1016/j.immuni.2008.02.005 · Cited by 955
Self-citationNod-like proteins in immunity, inflammation and disease
Fritz, J. H., Ferrero, R. L., Philpott, D. J., & Girardin, S. E. (2006) · Nature Immunology · doi:10.1038/ni1412 · Cited by 892
Metadata
- Authors
- Reith, W., & Mach, B.
- Venue
- Annual Review of Immunology
- Publisher
- Annual Reviews
- Published
- 2001-04
- Volume
- 19
- Issue
- 1
- Pages
- 331-373
- ISSN
- 0732-0582 (ISSN-L)
- 1545-3278
- OpenAlex
- W1920211008
- Cited by
- 518
- References
- 139
- FWCI
- 1.82
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.